A new trading day began on Monday, with Alx Oncology Holdings Inc (NASDAQ: ALXO) stock price down -4.90% from the previous day of trading, before settling in for the closing price of $0.66. ALXO’s price has ranged from $0.65 to $17.83 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -35.07%. Meanwhile, its annual earnings per share averaged 34.84%. With a float of $33.99 million, this company’s outstanding shares have now reached $53.05 million.
Let’s determine the extent of company efficiency that accounts for 80 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Alx Oncology Holdings Inc (ALXO) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Alx Oncology Holdings Inc is 36.33%, while institutional ownership is 56.31%. The most recent insider transaction that took place on Feb 19 ’25, was worth 633. In this transaction SVP, FINANCE AND CAO of this company sold 550 shares at a rate of $1.15, taking the stock ownership to the 87,352 shares. Before that another transaction happened on Feb 19 ’25, when Company’s PRESIDENT & CSO sold 1,326 for $1.15, making the entire transaction worth $1,525. This insider now owns 579,388 shares in total.
Alx Oncology Holdings Inc (ALXO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 34.84% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.88% during the next five years compared to -32.29% drop over the previous five years of trading.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators
Here are Alx Oncology Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.61, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -1.44 in one year’s time.
Technical Analysis of Alx Oncology Holdings Inc (ALXO)
Looking closely at Alx Oncology Holdings Inc (NASDAQ: ALXO), its last 5-days average volume was 0.39 million, which is a drop from its year-to-date volume of 1.06 million. As of the previous 9 days, the stock’s Stochastic %D was 15.33%. Additionally, its Average True Range was 0.09.
During the past 100 days, Alx Oncology Holdings Inc’s (ALXO) raw stochastic average was set at 2.18%, which indicates a significant decrease from 7.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.82% in the past 14 days, which was lower than the 115.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0967, while its 200-day Moving Average is $2.4597. However, in the short run, Alx Oncology Holdings Inc’s stock first resistance to watch stands at $0.6649. Second resistance stands at $0.7069. The third major resistance level sits at $0.7437. If the price goes on to break the first support level at $0.5861, it is likely to go to the next support level at $0.5493. Should the price break the second support level, the third support level stands at $0.5073.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Key Stats
With a market capitalization of 33.26 million, the company has a total of 53,384K Shares Outstanding. Currently, annual sales are 0 K while annual income is -134,850 K. The company’s previous quarter sales were 0 K while its latest quarter income was -29,160 K.
